Skip to main content

SILVERCREST ASSET MANAGEMENT GROUP LLC

Position in ZYME — Zymeworks Inc.

CIK 1232395 NEW YORK, NY

Position in ZYME

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$4,097,770
-$688,760 QoQ
Shares Held
163,649
-10.0% QoQ
Ownership
0.224%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2023
12 quarters on record
Voting authority Sole 63% Shared 0% None 37%

Common Shares in ZYME Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

SILVERCREST ASSET MANAGEMENT GROUP LLC holds $95,938,613 across 21 Biotechnology names. ZYME ranks #8 (4.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 ZYME
Zymeworks Inc.
This page
163,649 $4,097,770

All Filings in ZYME

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $4,097,770 163,649
2025-12-31 $4,786,530 181,790
2025-09-30 $4,659,372 272,797
2025-06-30 $3,523,111 280,726
2025-03-31 $3,343,446 280,726
2024-12-31 $4,133,530 282,345
2024-09-30 $3,578,193 285,115
2024-06-30 $3,388,205 398,144
2024-03-31 $4,134,580 393,021
2023-12-31 $3,905,060 375,848
2023-09-30 $2,382,876 375,848
2023-06-30 $3,255,534 376,798